Cannabis stocks carry the losses from Tuesday’s session into Wednesday morning, with US markets yet to open and all prices reflecting the 12 May close. As reported by Business of Cannabis, the sector closed Tuesday in broadly negative territory: 23 of 38 tracked tickers finished below their previous close, 13 advanced, and 2 held flat. Following Tuesday’s session, in which Cronos held at $2.75 as Ayr Wellness continued its slide toward penny-stock territory, the picture has deteriorated further across operators and Canadian licensed producers alike. OTC-quoted names carry a standard one-session data lag.
The headline move belongs to Organigram Holdings (OGI), which now sits at $1.11, down 15.27% from its prior close of $1.31 — the largest percentage decline across the Cannabis Stocks Today coverage universe on Tuesday. Incannex Healthcare (IXHL) is the second-largest decliner, sitting at $3.90 against a prior close of $4.53 (-13.91%). The ETF complex reflects the breadth of the retreat: the AdvisorShares Pure US Cannabis ETF (MSOS) currently trades at $4.88 (-3.56%), while the ETFMG Alternative Harvest ETF (MJ) holds at $26.22 (-3.07%). Against that backdrop, Corbus Pharmaceuticals (CRBP) offers the clearest positive data point at $11.43 (+3.53% against its prior close).
Four names stand out from Tuesday’s close. Organigram Holdings (OGI) sits at $1.11 after shedding 15.27%, a fall of $0.20 from the prior session’s $1.31. For one of the more established Canadian licensed producers, that represents a notable single-session retreat. Organigram has been navigating a challenging domestic environment characterised by persistent pricing pressure in the Canadian adult-use market and ongoing cost-optimisation efforts. At $1.11, the stock approaches recent lows; market participants will be watching whether that level holds as US markets open on Wednesday. No company announcement was publicly available to explain the scale of the move at time of publication.
Incannex Healthcare (IXHL) closes Tuesday at $3.90, off 13.91% from $4.53. The company is developing cannabis-derived and psychedelic-assisted medical therapies, and its share price has been subject to sharp moves given its early-stage profile and narrow float. At $3.90, the stock retreats below the $4.00 handle that had broadly contained it in the preceding sessions. No specific catalyst was available at time of writing; the depth of the move will attract attention if Wednesday’s session sustains the weakness.
Cresco Labs (CRLBF) now trades at $0.95, crossing below the $1.00 mark from a prior close of $1.007. That threshold carries practical weight for US multi-state operators: sub-$1 pricing affects eligibility for certain index products and can prompt institutional rebalancing at the margin. Down 5.66% on the session, Cresco is the fourth-largest decliner in Tuesday’s coverage universe. The Chicago-based operator has been working through capital structure pressures common to the broader US cannabis sector in the absence of federal reform progress.
The ETF complex tells the aggregate story most plainly. The AdvisorShares Pure US Cannabis ETF (MSOS) — the primary vehicle for institutional US cannabis exposure — sits at $4.88, down 3.56% from $5.06. The Amplify Seymour Cannabis ETF (CNBS) is at $28.15, off 3.30%, and the ETFMG Alternative Harvest ETF (MJ) at $26.22 represents a 3.07% decline. Across all four cannabis-focused ETFs in the Business of Cannabis Stocks Tracker, Tuesday saw consistent and material losses, pointing to broad rather than idiosyncratic selling. The AdvisorShares Pure Cannabis ETF (YOLO) edged lower by 1.20% to $3.04, rounding out a negative session for the ETF complex.
Entering Wednesday’s session, the cannabis sector carries a predominantly negative skew, with broad-based losses across ETFs, multi-state operators, and Canadian licensed producers. Cronos Group (CRON) at $2.77 (+0.73%) and Corbus Pharmaceuticals (CRBP) at $11.43 (+3.53%) offer the more meaningful positive data points, while benchmark names including Tilray Brands (TLRY, $5.41) and Curaleaf Holdings (CURLF, $3.86) remain in the red. Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.
The post Cannabis Stocks Today — Wednesday 13 May 2026: Organigram Slides to $1.11 as Sector Posts Broad Losses appeared first on Business of Cannabis.
Continue reading...
The headline move belongs to Organigram Holdings (OGI), which now sits at $1.11, down 15.27% from its prior close of $1.31 — the largest percentage decline across the Cannabis Stocks Today coverage universe on Tuesday. Incannex Healthcare (IXHL) is the second-largest decliner, sitting at $3.90 against a prior close of $4.53 (-13.91%). The ETF complex reflects the breadth of the retreat: the AdvisorShares Pure US Cannabis ETF (MSOS) currently trades at $4.88 (-3.56%), while the ETFMG Alternative Harvest ETF (MJ) holds at $26.22 (-3.07%). Against that backdrop, Corbus Pharmaceuticals (CRBP) offers the clearest positive data point at $11.43 (+3.53% against its prior close).
| OGI | Organigram Holdings | $1.11 | $-0.20 | -15.27% |
| IXHL | Incannex Healthcare | $3.90 | $-0.63 | -13.91% |
| VEXTF | Vext Science | $0.2124 | $-0.017 | -7.41% |
| CRLBF | Cresco Labs | $0.9500 | $-0.057 | -5.66% |
| TCNNF | Trulieve Cannabis | $8.10 | $-0.42 | -4.93% |
| GTBIF | Green Thumb Industries | $7.67 | $-0.36 | -4.48% |
| JUSHF | Jushi Holdings | $0.5000 | $-0.020 | -3.85% |
| MSOS | AdvisorShares Pure US Cannabis ETF | $4.88 | $-0.18 | -3.56% |
| CRBP | Corbus Pharmaceuticals | $11.43 | +$0.39 | +3.53% |
| CNBS | Amplify Seymour Cannabis ETF | $28.15 | $-0.96 | -3.30% |
| IPW | iPower Inc. | $0.7799 | +$0.025 | +3.30% |
| CURLF | Curaleaf Holdings | $3.86 | $-0.13 | -3.26% |
| MJ | ETFMG Alternative Harvest ETF | $26.22 | $-0.83 | -3.07% |
| CGC | Canopy Growth® Corporation | $1.09 | $-0.030 | -2.68% |
| AAWH | Acreage Holdings | $0.5499 | $-0.015 | -2.66% |
| MAPS | WM Technology (Weedmaps) | $0.3900 | +$0.010 | +2.63% |
| ABBV | AbbVie Inc. | $207.86 | +$5.08 | +2.51% |
| GRWG | GrowGeneration Corp | $1.37 | $-0.030 | -2.14% |
| HITI | High Tide Inc. | $2.43 | $-0.050 | -2.02% |
| JAZZ | Jazz Pharmaceuticals | $227.84 | +$4.23 | +1.89% |
| MO | Altria Group | $69.89 | +$1.28 | +1.87% |
| TLRY | Tilray Brands | $5.41 | $-0.10 | -1.81% |
| ACB | Aurora® Cannabis | $3.36 | $-0.060 | -1.75% |
| REFI | Chicago Atlantic Real Estate Finance | $11.38 | $-0.20 | -1.73% |
| GLASF | Glass House Brands | $9.21 | $-0.14 | -1.50% |
| SNDL | SNDL Inc. | $1.41 | $-0.020 | -1.40% |
| IIPR | Innovative Industrial Properties | $55.76 | $-0.73 | -1.29% |
| YOLO | AdvisorShares Pure Cannabis ETF | $3.04 | $-0.037 | -1.20% |
| VFF | Village Farms International | $2.67 | +$0.030 | +1.14% |
| AFCG | AFC Gamma | $3.26 | +$0.030 | +0.93% |
| SMG | The Scotts Miracle-Gro Company | $59.57 | $-0.46 | -0.77% |
| CRON | Cronos Group | $2.77 | +$0.020 | +0.73% |
| TPB | Turning Point Brands | $92.96 | +$0.25 | +0.27% |
| IMCC | IM Cannabis Corp | $0.2515 | +$0.0005 | +0.20% |
| CBWTF | Cannabist Company Holdings | $0.1008 | +$0.0001 | +0.10% |
| STZ | Constellation Brands | $142.53 | +$0.12 | +0.08% |
| AYRWF | Ayr Wellness | $0.0120 | $0.00 | 0.00% |
| EEX | Emerald Expositions Events | $4.99 | $0.00 | 0.00% |
[th]
Ticker
[/th][th]
Company
[/th][th]
Current Price
[/th][th]
Change ($)
[/th][th]
Change (%)
[/th]Four names stand out from Tuesday’s close. Organigram Holdings (OGI) sits at $1.11 after shedding 15.27%, a fall of $0.20 from the prior session’s $1.31. For one of the more established Canadian licensed producers, that represents a notable single-session retreat. Organigram has been navigating a challenging domestic environment characterised by persistent pricing pressure in the Canadian adult-use market and ongoing cost-optimisation efforts. At $1.11, the stock approaches recent lows; market participants will be watching whether that level holds as US markets open on Wednesday. No company announcement was publicly available to explain the scale of the move at time of publication.
Incannex Healthcare (IXHL) closes Tuesday at $3.90, off 13.91% from $4.53. The company is developing cannabis-derived and psychedelic-assisted medical therapies, and its share price has been subject to sharp moves given its early-stage profile and narrow float. At $3.90, the stock retreats below the $4.00 handle that had broadly contained it in the preceding sessions. No specific catalyst was available at time of writing; the depth of the move will attract attention if Wednesday’s session sustains the weakness.
Cresco Labs (CRLBF) now trades at $0.95, crossing below the $1.00 mark from a prior close of $1.007. That threshold carries practical weight for US multi-state operators: sub-$1 pricing affects eligibility for certain index products and can prompt institutional rebalancing at the margin. Down 5.66% on the session, Cresco is the fourth-largest decliner in Tuesday’s coverage universe. The Chicago-based operator has been working through capital structure pressures common to the broader US cannabis sector in the absence of federal reform progress.
The ETF complex tells the aggregate story most plainly. The AdvisorShares Pure US Cannabis ETF (MSOS) — the primary vehicle for institutional US cannabis exposure — sits at $4.88, down 3.56% from $5.06. The Amplify Seymour Cannabis ETF (CNBS) is at $28.15, off 3.30%, and the ETFMG Alternative Harvest ETF (MJ) at $26.22 represents a 3.07% decline. Across all four cannabis-focused ETFs in the Business of Cannabis Stocks Tracker, Tuesday saw consistent and material losses, pointing to broad rather than idiosyncratic selling. The AdvisorShares Pure Cannabis ETF (YOLO) edged lower by 1.20% to $3.04, rounding out a negative session for the ETF complex.
Entering Wednesday’s session, the cannabis sector carries a predominantly negative skew, with broad-based losses across ETFs, multi-state operators, and Canadian licensed producers. Cronos Group (CRON) at $2.77 (+0.73%) and Corbus Pharmaceuticals (CRBP) at $11.43 (+3.53%) offer the more meaningful positive data points, while benchmark names including Tilray Brands (TLRY, $5.41) and Curaleaf Holdings (CURLF, $3.86) remain in the red. Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.
The post Cannabis Stocks Today — Wednesday 13 May 2026: Organigram Slides to $1.11 as Sector Posts Broad Losses appeared first on Business of Cannabis.
Continue reading...
